Effects of BM-573, a novel thromboxane A2 inhibitor, on pulmonary hemodynamics in endotoxic shock.
D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D010101:Oxygen Consumption; D010313:Partial Pressure; D010974:Platelet Aggregation / Q000187:drug effects; D011651:Pulmonary Artery / Q000187:drug effects / Q000502:physiology; D011652:Pulmonary Circulation / Q000187:drug effects*; D012772:Shock, Septic / Q000503:physiopathology*; D013453:Sulfonylurea Compounds / Q000737:chemistry / Q000494:pharmacology*; D013552:Swine; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis
C475768:N-terbutyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea; D013453:Sulfonylurea Compounds; D016718:Arachidonic Acid; D013928:Thromboxane A2